Journal of antivirals and antiretrovirals is one of the top journals in the current field of virology which publishes novel work in the form of different article types such as research or review articles. This journal acts as a barrier for exchange of scientific knowledge among researchers and scientists.
Antiviral Chemistry & Chemotherapy covers research on all aspects such as preclinical development of antiviral drugs, including their chemical and biochemical synthesis, biochemistry, pharmacology, mode of action, and studies on virology, as well as studies in animal models. The large number of useful antiviral compounds is increasing rapidly day by day. Although most of the recent attempts to develop new antiviral agents have been focused highly on RNA viruses (in particularly, HIV and hepatitis C virus), a few new compounds are now ready to entry into the important fields of DNA viruses. Most of the compounds are arranged by virus targets thus they are divided into many inhibitors such as RNA viruses and retroviruses, particularly poxviruses, such as variola virus, because of the bioterrorist context, and herpes viruses, such as herpes simplex virus and cytomegalovirus, where the market scene has for many years been dominated by acyclovir, penciclovir and ganciclovir and their respective orally bioavailable prodrugs: valaciclovir, famciclovir and valganciclovir
OMICS Group has more than 700+ peer-reviewed journals which are publishing quality articles.
Authors have an opportunity to use the newly launched Translation Services. Experienced translators translate the submission to the required native languages such as French, German, Spanish, Chinese, Japanese or English. Therefore, we guarantee the best exchange of knowledge and expertise to your targeted audience. The translation process is always followed by strict review procedures to ensure absolute accuracy. This guarantees free communication and exchange between scientists and creates more opportunities for future research on around the world.
Last date updated on September, 2024